nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—ABCC1—Methotrexate—esophageal cancer	0.0809	0.684	CbGbCtD
Abiraterone—ALB—Methotrexate—esophageal cancer	0.0373	0.316	CbGbCtD
Abiraterone—Potassium low—Capecitabine—esophageal cancer	0.0172	0.0573	CcSEcCtD
Abiraterone—Blood potassium decreased—Capecitabine—esophageal cancer	0.0095	0.0316	CcSEcCtD
Abiraterone—Hypophosphataemia—Cisplatin—esophageal cancer	0.00843	0.028	CcSEcCtD
Abiraterone—Joint swelling—Capecitabine—esophageal cancer	0.00736	0.0245	CcSEcCtD
Abiraterone—Lymphopenia—Capecitabine—esophageal cancer	0.00706	0.0235	CcSEcCtD
Abiraterone—Sudden death—Capecitabine—esophageal cancer	0.00706	0.0235	CcSEcCtD
Abiraterone—Hepatotoxicity—Cisplatin—esophageal cancer	0.00635	0.0211	CcSEcCtD
Abiraterone—Hypertriglyceridaemia—Capecitabine—esophageal cancer	0.00629	0.0209	CcSEcCtD
Abiraterone—Infection—Carboplatin—esophageal cancer	0.00592	0.0197	CcSEcCtD
Abiraterone—Blood triglycerides increased—Capecitabine—esophageal cancer	0.00551	0.0183	CcSEcCtD
Abiraterone—Sudden death—Methotrexate—esophageal cancer	0.00525	0.0175	CcSEcCtD
Abiraterone—Body temperature increased—Carboplatin—esophageal cancer	0.00471	0.0157	CcSEcCtD
Abiraterone—Hepatotoxicity—Capecitabine—esophageal cancer	0.00468	0.0156	CcSEcCtD
Abiraterone—Testosterone—CYP1B1—esophageal cancer	0.00468	0.495	CrCbGaD
Abiraterone—Fluid retention—Cisplatin—esophageal cancer	0.00465	0.0155	CcSEcCtD
Abiraterone—Fracture—Methotrexate—esophageal cancer	0.00463	0.0154	CcSEcCtD
Abiraterone—Multiple fractures—Methotrexate—esophageal cancer	0.00463	0.0154	CcSEcCtD
Abiraterone—Myocardial ischaemia—Capecitabine—esophageal cancer	0.00449	0.0149	CcSEcCtD
Abiraterone—Contusion—Capecitabine—esophageal cancer	0.00414	0.0138	CcSEcCtD
Abiraterone—Chest discomfort—Capecitabine—esophageal cancer	0.00408	0.0136	CcSEcCtD
Abiraterone—Nocturia—Capecitabine—esophageal cancer	0.00389	0.0129	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.00361	0.012	CcSEcCtD
Abiraterone—Hepatotoxicity—Methotrexate—esophageal cancer	0.00348	0.0116	CcSEcCtD
Abiraterone—Testosterone—CYP19A1—esophageal cancer	0.00343	0.363	CrCbGaD
Abiraterone—Fluid retention—Capecitabine—esophageal cancer	0.00343	0.0114	CcSEcCtD
Abiraterone—Hypokalaemia—Cisplatin—esophageal cancer	0.00324	0.0108	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.0032	0.0107	CcSEcCtD
Abiraterone—Nasopharyngitis—Cisplatin—esophageal cancer	0.00318	0.0106	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00301	0.01	CcSEcCtD
Abiraterone—Hot flush—Capecitabine—esophageal cancer	0.0028	0.00932	CcSEcCtD
Abiraterone—Menopausal symptoms—Capecitabine—esophageal cancer	0.00278	0.00924	CcSEcCtD
Abiraterone—Acute coronary syndrome—Cisplatin—esophageal cancer	0.0027	0.00899	CcSEcCtD
Abiraterone—Myocardial infarction—Cisplatin—esophageal cancer	0.00269	0.00893	CcSEcCtD
Abiraterone—Cardiac failure—Capecitabine—esophageal cancer	0.00269	0.00893	CcSEcCtD
Abiraterone—Urinary tract disorder—Cisplatin—esophageal cancer	0.00243	0.00808	CcSEcCtD
Abiraterone—Connective tissue disorder—Cisplatin—esophageal cancer	0.00242	0.00804	CcSEcCtD
Abiraterone—Urethral disorder—Cisplatin—esophageal cancer	0.00241	0.00802	CcSEcCtD
Abiraterone—Hypokalaemia—Capecitabine—esophageal cancer	0.00239	0.00793	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00236	0.00785	CcSEcCtD
Abiraterone—Nasopharyngitis—Capecitabine—esophageal cancer	0.00234	0.0078	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00231	0.00769	CcSEcCtD
Abiraterone—Cardiac disorder—Cisplatin—esophageal cancer	0.00228	0.00759	CcSEcCtD
Abiraterone—Mediastinal disorder—Cisplatin—esophageal cancer	0.00222	0.00737	CcSEcCtD
Abiraterone—Arrhythmia—Cisplatin—esophageal cancer	0.0022	0.00731	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00211	0.007	CcSEcCtD
Abiraterone—Hyperglycaemia—Capecitabine—esophageal cancer	0.00204	0.0068	CcSEcCtD
Abiraterone—Pneumonia—Capecitabine—esophageal cancer	0.00203	0.00676	CcSEcCtD
Abiraterone—Infestation NOS—Capecitabine—esophageal cancer	0.00202	0.00672	CcSEcCtD
Abiraterone—Infestation—Capecitabine—esophageal cancer	0.00202	0.00672	CcSEcCtD
Abiraterone—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00199	0.00662	CcSEcCtD
Abiraterone—Myocardial infarction—Capecitabine—esophageal cancer	0.00198	0.00659	CcSEcCtD
Abiraterone—Anaemia—Cisplatin—esophageal cancer	0.00198	0.00658	CcSEcCtD
Abiraterone—Urinary tract infection—Capecitabine—esophageal cancer	0.00196	0.00653	CcSEcCtD
Abiraterone—Haematuria—Capecitabine—esophageal cancer	0.00193	0.00641	CcSEcCtD
Abiraterone—Myalgia—Cisplatin—esophageal cancer	0.00182	0.00606	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00181	0.00602	CcSEcCtD
Abiraterone—Discomfort—Cisplatin—esophageal cancer	0.0018	0.00599	CcSEcCtD
Abiraterone—Urinary tract disorder—Capecitabine—esophageal cancer	0.00179	0.00596	CcSEcCtD
Abiraterone—Connective tissue disorder—Capecitabine—esophageal cancer	0.00178	0.00593	CcSEcCtD
Abiraterone—Urethral disorder—Capecitabine—esophageal cancer	0.00178	0.00591	CcSEcCtD
Abiraterone—Oedema—Cisplatin—esophageal cancer	0.00175	0.00581	CcSEcCtD
Abiraterone—Infection—Cisplatin—esophageal cancer	0.00174	0.00578	CcSEcCtD
Abiraterone—Skin disorder—Cisplatin—esophageal cancer	0.0017	0.00565	CcSEcCtD
Abiraterone—Cardiac disorder—Capecitabine—esophageal cancer	0.00168	0.0056	CcSEcCtD
Abiraterone—Angiopathy—Capecitabine—esophageal cancer	0.00165	0.00547	CcSEcCtD
Abiraterone—Mediastinal disorder—Capecitabine—esophageal cancer	0.00163	0.00544	CcSEcCtD
Abiraterone—Arrhythmia—Capecitabine—esophageal cancer	0.00162	0.00539	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00159	0.0053	CcSEcCtD
Abiraterone—Mental disorder—Capecitabine—esophageal cancer	0.00159	0.00528	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00157	0.00521	CcSEcCtD
Abiraterone—Dyspnoea—Cisplatin—esophageal cancer	0.00156	0.00518	CcSEcCtD
Abiraterone—Pneumonia—Methotrexate—esophageal cancer	0.00151	0.00503	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00151	0.00502	CcSEcCtD
Abiraterone—Infestation NOS—Methotrexate—esophageal cancer	0.0015	0.005	CcSEcCtD
Abiraterone—Infestation—Methotrexate—esophageal cancer	0.0015	0.005	CcSEcCtD
Abiraterone—Anaemia—Capecitabine—esophageal cancer	0.00146	0.00485	CcSEcCtD
Abiraterone—Haematuria—Methotrexate—esophageal cancer	0.00143	0.00477	CcSEcCtD
Abiraterone—Body temperature increased—Cisplatin—esophageal cancer	0.00138	0.0046	CcSEcCtD
Abiraterone—Cough—Capecitabine—esophageal cancer	0.00138	0.00458	CcSEcCtD
Abiraterone—Hypertension—Capecitabine—esophageal cancer	0.00136	0.00453	CcSEcCtD
Abiraterone—Chest pain—Capecitabine—esophageal cancer	0.00134	0.00447	CcSEcCtD
Abiraterone—Myalgia—Capecitabine—esophageal cancer	0.00134	0.00447	CcSEcCtD
Abiraterone—Testosterone—ABCB1—esophageal cancer	0.00134	0.142	CrCbGaD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00134	0.00444	CcSEcCtD
Abiraterone—Urinary tract disorder—Methotrexate—esophageal cancer	0.00133	0.00443	CcSEcCtD
Abiraterone—Discomfort—Capecitabine—esophageal cancer	0.00133	0.00442	CcSEcCtD
Abiraterone—Urethral disorder—Methotrexate—esophageal cancer	0.00132	0.0044	CcSEcCtD
Abiraterone—Oedema—Capecitabine—esophageal cancer	0.00129	0.00429	CcSEcCtD
Abiraterone—Infection—Capecitabine—esophageal cancer	0.00128	0.00426	CcSEcCtD
Abiraterone—Asthenia—Cisplatin—esophageal cancer	0.00125	0.00417	CcSEcCtD
Abiraterone—Cardiac disorder—Methotrexate—esophageal cancer	0.00125	0.00417	CcSEcCtD
Abiraterone—Skin disorder—Capecitabine—esophageal cancer	0.00125	0.00416	CcSEcCtD
Abiraterone—Angiopathy—Methotrexate—esophageal cancer	0.00123	0.00407	CcSEcCtD
Abiraterone—Mediastinal disorder—Methotrexate—esophageal cancer	0.00122	0.00405	CcSEcCtD
Abiraterone—Diarrhoea—Cisplatin—esophageal cancer	0.0012	0.00398	CcSEcCtD
Abiraterone—Mental disorder—Methotrexate—esophageal cancer	0.00118	0.00393	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00117	0.0039	CcSEcCtD
Abiraterone—Insomnia—Capecitabine—esophageal cancer	0.00117	0.00388	CcSEcCtD
Abiraterone—Dyspnoea—Capecitabine—esophageal cancer	0.00115	0.00382	CcSEcCtD
Abiraterone—Dyspepsia—Capecitabine—esophageal cancer	0.00113	0.00377	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00111	0.0037	CcSEcCtD
Abiraterone—Vomiting—Cisplatin—esophageal cancer	0.00111	0.0037	CcSEcCtD
Abiraterone—Fatigue—Capecitabine—esophageal cancer	0.00111	0.00369	CcSEcCtD
Abiraterone—Rash—Cisplatin—esophageal cancer	0.0011	0.00367	CcSEcCtD
Abiraterone—Constipation—Capecitabine—esophageal cancer	0.0011	0.00366	CcSEcCtD
Abiraterone—Dermatitis—Cisplatin—esophageal cancer	0.0011	0.00366	CcSEcCtD
Abiraterone—Anaemia—Methotrexate—esophageal cancer	0.00109	0.00361	CcSEcCtD
Abiraterone—Cough—Methotrexate—esophageal cancer	0.00103	0.00341	CcSEcCtD
Abiraterone—Body temperature increased—Capecitabine—esophageal cancer	0.00102	0.00339	CcSEcCtD
Abiraterone—Chest pain—Methotrexate—esophageal cancer	0.001	0.00333	CcSEcCtD
Abiraterone—Myalgia—Methotrexate—esophageal cancer	0.001	0.00333	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000994	0.0033	CcSEcCtD
Abiraterone—Discomfort—Methotrexate—esophageal cancer	0.000989	0.00329	CcSEcCtD
Abiraterone—Infection—Methotrexate—esophageal cancer	0.000953	0.00317	CcSEcCtD
Abiraterone—Skin disorder—Methotrexate—esophageal cancer	0.000932	0.0031	CcSEcCtD
Abiraterone—Asthenia—Capecitabine—esophageal cancer	0.000925	0.00307	CcSEcCtD
Abiraterone—Diarrhoea—Capecitabine—esophageal cancer	0.000882	0.00293	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000874	0.00291	CcSEcCtD
Abiraterone—Insomnia—Methotrexate—esophageal cancer	0.000868	0.00289	CcSEcCtD
Abiraterone—Dyspnoea—Methotrexate—esophageal cancer	0.000855	0.00284	CcSEcCtD
Abiraterone—Dyspepsia—Methotrexate—esophageal cancer	0.000844	0.00281	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000828	0.00275	CcSEcCtD
Abiraterone—Fatigue—Methotrexate—esophageal cancer	0.000827	0.00275	CcSEcCtD
Abiraterone—Vomiting—Capecitabine—esophageal cancer	0.000819	0.00272	CcSEcCtD
Abiraterone—Rash—Capecitabine—esophageal cancer	0.000813	0.0027	CcSEcCtD
Abiraterone—Dermatitis—Capecitabine—esophageal cancer	0.000812	0.0027	CcSEcCtD
Abiraterone—Body temperature increased—Methotrexate—esophageal cancer	0.000758	0.00252	CcSEcCtD
Abiraterone—Asthenia—Methotrexate—esophageal cancer	0.000688	0.00229	CcSEcCtD
Abiraterone—Diarrhoea—Methotrexate—esophageal cancer	0.000656	0.00218	CcSEcCtD
Abiraterone—Vomiting—Methotrexate—esophageal cancer	0.00061	0.00203	CcSEcCtD
Abiraterone—Rash—Methotrexate—esophageal cancer	0.000605	0.00201	CcSEcCtD
Abiraterone—Dermatitis—Methotrexate—esophageal cancer	0.000604	0.00201	CcSEcCtD
Abiraterone—ABCC1—Disease—ELMO1—esophageal cancer	0.000224	0.000392	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ENO1—esophageal cancer	0.000221	0.000387	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTGS1—esophageal cancer	0.000221	0.000387	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.00022	0.000386	CbGpPWpGaD
Abiraterone—ABCC1—Disease—GSTO1—esophageal cancer	0.000219	0.000383	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TPI1—esophageal cancer	0.000219	0.000383	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PSME2—esophageal cancer	0.000218	0.000381	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PSME1—esophageal cancer	0.000218	0.000381	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—GNG7—esophageal cancer	0.000214	0.000374	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ADH1B—esophageal cancer	0.000212	0.000371	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ALDOB—esophageal cancer	0.00021	0.000367	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—TP53—esophageal cancer	0.000208	0.000363	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000208	0.000363	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000206	0.00036	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000205	0.000358	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000204	0.000357	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—TYMP—esophageal cancer	0.000203	0.000355	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HIST1H2BM—esophageal cancer	0.000202	0.000354	CbGpPWpGaD
Abiraterone—ABCC1—Disease—GAPDH—esophageal cancer	0.000202	0.000354	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000199	0.000349	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP26A1—esophageal cancer	0.000197	0.000345	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CREBBP—esophageal cancer	0.000195	0.000341	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000194	0.00034	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ALOX15—esophageal cancer	0.000192	0.000336	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000192	0.000335	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.00019	0.000333	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP1B1—esophageal cancer	0.000188	0.000329	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000185	0.000324	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTO1—esophageal cancer	0.000183	0.000321	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—TPI1—esophageal cancer	0.000183	0.000321	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—BLVRB—esophageal cancer	0.000183	0.00032	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC52A3—esophageal cancer	0.000183	0.00032	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000183	0.000319	CbGpPWpGaD
Abiraterone—ALB—Metabolism—BLVRB—esophageal cancer	0.000182	0.000318	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC52A3—esophageal cancer	0.000182	0.000318	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00018	0.000315	CbGpPWpGaD
Abiraterone—ABCC1—Disease—XIAP—esophageal cancer	0.000179	0.000312	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP19A1—esophageal cancer	0.000177	0.000309	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ALDOB—esophageal cancer	0.000176	0.000308	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—NOS3—esophageal cancer	0.000174	0.000305	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—HSPA5—esophageal cancer	0.000174	0.000305	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GAPDH—esophageal cancer	0.000169	0.000296	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CRABP1—esophageal cancer	0.000168	0.000294	CbGpPWpGaD
Abiraterone—ABCC1—Disease—B2M—esophageal cancer	0.000166	0.00029	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000163	0.000286	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000163	0.000284	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—HMOX1—esophageal cancer	0.000161	0.000282	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GNG7—esophageal cancer	0.00016	0.000279	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PTGS2—esophageal cancer	0.00016	0.000279	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ENO1—esophageal cancer	0.000159	0.000278	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000158	0.000277	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PSME2—esophageal cancer	0.000157	0.000274	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PSME1—esophageal cancer	0.000157	0.000274	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC10A2—esophageal cancer	0.000155	0.000272	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CA1—esophageal cancer	0.000155	0.000272	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ABCB1—esophageal cancer	0.000155	0.000271	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CA1—esophageal cancer	0.000155	0.00027	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC10A2—esophageal cancer	0.000155	0.00027	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CALR—esophageal cancer	0.000151	0.000263	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.00015	0.000263	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.00015	0.000263	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ALDH2—esophageal cancer	0.00015	0.000262	CbGpPWpGaD
Abiraterone—ABCC1—Disease—FBXW7—esophageal cancer	0.000146	0.000255	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTT1—esophageal cancer	0.000142	0.000249	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CA2—esophageal cancer	0.000142	0.000249	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CA2—esophageal cancer	0.000141	0.000247	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP2A6—esophageal cancer	0.000141	0.000246	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.00014	0.000245	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000139	0.000243	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000138	0.000242	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTGS1—esophageal cancer	0.000133	0.000233	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ENO1—esophageal cancer	0.000133	0.000233	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000133	0.000233	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—EP300—esophageal cancer	0.000133	0.000232	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ADH7—esophageal cancer	0.000132	0.000231	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PLCE1—esophageal cancer	0.000132	0.000231	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PLCE1—esophageal cancer	0.000131	0.00023	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ADH7—esophageal cancer	0.000131	0.00023	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PSME1—esophageal cancer	0.000131	0.00023	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PSME2—esophageal cancer	0.000131	0.00023	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000131	0.000229	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00013	0.000227	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—ABL1—esophageal cancer	0.000129	0.000226	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000128	0.000223	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CA1—esophageal cancer	0.000128	0.000223	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TGFBR2—esophageal cancer	0.000118	0.000206	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000117	0.000205	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CA2—esophageal cancer	0.000117	0.000204	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ADH1B—esophageal cancer	0.000116	0.000203	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ADH1B—esophageal cancer	0.000115	0.000202	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000115	0.000201	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP1B1—esophageal cancer	0.000113	0.000198	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000113	0.000197	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SMAD4—esophageal cancer	0.000111	0.000195	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—TYMP—esophageal cancer	0.000111	0.000194	CbGpPWpGaD
Abiraterone—ALB—Metabolism—TYMP—esophageal cancer	0.00011	0.000193	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000109	0.00019	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000109	0.00019	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000108	0.000189	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP26A1—esophageal cancer	0.000108	0.000189	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP26A1—esophageal cancer	0.000107	0.000187	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP19A1—esophageal cancer	0.000107	0.000186	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALOX15—esophageal cancer	0.000105	0.000184	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ALOX15—esophageal cancer	0.000104	0.000183	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CREBBP—esophageal cancer	0.000103	0.000181	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—TPI1—esophageal cancer	0.0001	0.000175	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTO1—esophageal cancer	0.0001	0.000175	CbGpPWpGaD
Abiraterone—ALB—Metabolism—TPI1—esophageal cancer	9.96e-05	0.000174	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTO1—esophageal cancer	9.96e-05	0.000174	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PIK3CA—esophageal cancer	9.82e-05	0.000172	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—BLVRB—esophageal cancer	9.81e-05	0.000172	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	9.81e-05	0.000172	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—HMOX1—esophageal cancer	9.72e-05	0.00017	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALDOB—esophageal cancer	9.6e-05	0.000168	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ALDOB—esophageal cancer	9.55e-05	0.000167	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.54e-05	0.000167	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ADH1B—esophageal cancer	9.52e-05	0.000166	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ABCB1—esophageal cancer	9.33e-05	0.000163	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—NOS2—esophageal cancer	9.3e-05	0.000163	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—NOS3—esophageal cancer	9.26e-05	0.000162	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GAPDH—esophageal cancer	9.24e-05	0.000162	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GAPDH—esophageal cancer	9.19e-05	0.000161	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CRABP1—esophageal cancer	9.16e-05	0.00016	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HIF1A—esophageal cancer	9.12e-05	0.00016	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CRABP1—esophageal cancer	9.11e-05	0.000159	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TYMP—esophageal cancer	9.09e-05	0.000159	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP26A1—esophageal cancer	8.85e-05	0.000155	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GNG7—esophageal cancer	8.71e-05	0.000152	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GNG7—esophageal cancer	8.67e-05	0.000152	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALOX15—esophageal cancer	8.62e-05	0.000151	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTGS2—esophageal cancer	8.47e-05	0.000148	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—CREBBP—esophageal cancer	8.35e-05	0.000146	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	8.34e-05	0.000146	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CA1—esophageal cancer	8.34e-05	0.000146	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NOS2—esophageal cancer	8.29e-05	0.000145	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTO1—esophageal cancer	8.22e-05	0.000144	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TPI1—esophageal cancer	8.22e-05	0.000144	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NOTCH1—esophageal cancer	8.21e-05	0.000144	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALDH2—esophageal cancer	8.17e-05	0.000143	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	8.16e-05	0.000143	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ALDH2—esophageal cancer	8.12e-05	0.000142	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALDOB—esophageal cancer	7.88e-05	0.000138	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTT1—esophageal cancer	7.77e-05	0.000136	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTT1—esophageal cancer	7.72e-05	0.000135	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP2A6—esophageal cancer	7.68e-05	0.000134	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.65e-05	0.000134	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP2A6—esophageal cancer	7.63e-05	0.000134	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CA2—esophageal cancer	7.63e-05	0.000134	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.6e-05	0.000133	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GAPDH—esophageal cancer	7.59e-05	0.000133	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CRABP1—esophageal cancer	7.52e-05	0.000132	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—NOS3—esophageal cancer	7.48e-05	0.000131	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CREBBP—esophageal cancer	7.45e-05	0.00013	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTGS1—esophageal cancer	7.28e-05	0.000127	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ENO1—esophageal cancer	7.28e-05	0.000127	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ENO1—esophageal cancer	7.24e-05	0.000127	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTGS1—esophageal cancer	7.24e-05	0.000127	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.23e-05	0.000127	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PSME2—esophageal cancer	7.17e-05	0.000125	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PSME1—esophageal cancer	7.17e-05	0.000125	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GNG7—esophageal cancer	7.15e-05	0.000125	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PSME2—esophageal cancer	7.13e-05	0.000125	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PSME1—esophageal cancer	7.13e-05	0.000125	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PLCE1—esophageal cancer	7.09e-05	0.000124	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ADH7—esophageal cancer	7.09e-05	0.000124	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.06e-05	0.000123	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—EP300—esophageal cancer	7.04e-05	0.000123	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALDH2—esophageal cancer	6.7e-05	0.000117	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NOS3—esophageal cancer	6.67e-05	0.000117	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTT1—esophageal cancer	6.38e-05	0.000112	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP2A6—esophageal cancer	6.3e-05	0.00011	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.26e-05	0.00011	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CREBBP—esophageal cancer	6.24e-05	0.000109	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ERBB2—esophageal cancer	6.24e-05	0.000109	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.23e-05	0.000109	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ADH1B—esophageal cancer	6.22e-05	0.000109	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1B1—esophageal cancer	6.19e-05	0.000108	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1B1—esophageal cancer	6.15e-05	0.000108	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTGS2—esophageal cancer	6.1e-05	0.000107	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ENO1—esophageal cancer	5.98e-05	0.000105	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTGS1—esophageal cancer	5.98e-05	0.000105	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TYMP—esophageal cancer	5.95e-05	0.000104	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PSME2—esophageal cancer	5.89e-05	0.000103	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PSME1—esophageal cancer	5.89e-05	0.000103	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP19A1—esophageal cancer	5.82e-05	0.000102	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP19A1—esophageal cancer	5.79e-05	0.000101	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	5.78e-05	0.000101	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—EP300—esophageal cancer	5.69e-05	9.95e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALOX15—esophageal cancer	5.64e-05	9.86e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—NOS3—esophageal cancer	5.58e-05	9.77e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTO1—esophageal cancer	5.38e-05	9.41e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TPI1—esophageal cancer	5.38e-05	9.41e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN1A—esophageal cancer	5.33e-05	9.33e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HMOX1—esophageal cancer	5.31e-05	9.29e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HMOX1—esophageal cancer	5.28e-05	9.24e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CA—esophageal cancer	5.21e-05	9.11e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.21e-05	9.11e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.18e-05	9.06e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.16e-05	9.02e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTGS2—esophageal cancer	5.11e-05	8.94e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ABCB1—esophageal cancer	5.1e-05	8.92e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1B1—esophageal cancer	5.08e-05	8.89e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EP300—esophageal cancer	5.07e-05	8.87e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ABCB1—esophageal cancer	5.07e-05	8.87e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GAPDH—esophageal cancer	4.96e-05	8.68e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CRABP1—esophageal cancer	4.92e-05	8.6e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP19A1—esophageal cancer	4.78e-05	8.36e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GNG7—esophageal cancer	4.68e-05	8.18e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MYC—esophageal cancer	4.42e-05	7.73e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.38e-05	7.67e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HMOX1—esophageal cancer	4.36e-05	7.63e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EGFR—esophageal cancer	4.32e-05	7.56e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—EP300—esophageal cancer	4.25e-05	7.43e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CA—esophageal cancer	4.21e-05	7.36e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCB1—esophageal cancer	4.18e-05	7.32e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.17e-05	7.29e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.12e-05	7.21e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TP53—esophageal cancer	4.07e-05	7.12e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ENO1—esophageal cancer	3.91e-05	6.83e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTGS1—esophageal cancer	3.91e-05	6.83e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.85e-05	6.74e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PSME2—esophageal cancer	3.85e-05	6.73e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PSME1—esophageal cancer	3.85e-05	6.73e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.83e-05	6.7e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CA—esophageal cancer	3.75e-05	6.56e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CREBBP—esophageal cancer	3.41e-05	5.96e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CREBBP—esophageal cancer	3.39e-05	5.92e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.32e-05	5.81e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CA—esophageal cancer	3.14e-05	5.5e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.12e-05	5.46e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NOS3—esophageal cancer	3.05e-05	5.34e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NOS3—esophageal cancer	3.03e-05	5.3e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.85e-05	4.99e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CREBBP—esophageal cancer	2.8e-05	4.89e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTGS2—esophageal cancer	2.79e-05	4.88e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTGS2—esophageal cancer	2.77e-05	4.85e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.74e-05	4.79e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NOS3—esophageal cancer	2.5e-05	4.38e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—EP300—esophageal cancer	2.32e-05	4.06e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—EP300—esophageal cancer	2.31e-05	4.04e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.29e-05	4.01e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—EP300—esophageal cancer	1.9e-05	3.33e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.83e-05	3.2e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CA—esophageal cancer	1.72e-05	3e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CA—esophageal cancer	1.71e-05	2.99e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NOS3—esophageal cancer	1.64e-05	2.86e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.5e-05	2.62e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.41e-05	2.46e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—EP300—esophageal cancer	1.25e-05	2.18e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	9.21e-06	1.61e-05	CbGpPWpGaD
